SPOP and Ewing sarcoma: Together, these data further support a physiological role of SPOPCUL3 in targeting EWS–FLI1 for degradation and suggest that Ewing sarcoma tumors may inactivate SPOP‐mediated EWS–FLI1 degradation through CUL3 mutations to promote Ewing sarcoma growth.